In agreement with in vitro findings, NaBu significantly reduced hepatic TNF-α protein expression (Fig. 1F) and proinflammatory gene expressions (Fig. 1G) along with concomitant reduction in steatosis and infiltrations of inflammatory cells in the liver parenchyma (Fig. 1E). Here, TNF is linked to steatosis.